Patiromer Disease Interactions
There are 2 disease interactions with patiromer.
Patiromer (applies to patiromer) gastrointestinal motility
Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Obstruction, Constipation
The use of patiromer should be avoided in patients with severe constipation, bowel obstruction or impaction, including abnormal post-operative bowel motility disorders, as this agent may be ineffective and may worsen gastrointestinal conditions. Therapy with patiromer should be administered cautiously in patients with a history of bowel obstruction or major gastrointestinal surgery, severe gastrointestinal disorders, or swallowing disorders.
Patiromer (applies to patiromer) hypomagnesemia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Diarrhea, Magnesium Imbalance
Patiromer binds to magnesium in the colon, which can lead to hypomagnesemia. It is recommended to monitor serum magnesium concentrations during therapy. Therapy with patiromer should be administered cautiously in patients with or predisposed to magnesium deficiency. Consider magnesium supplementation in patients who develop low serum magnesium levels.
Switch to professional interaction data
Patiromer drug interactions
There are 104 drug interactions with patiromer.
Patiromer alcohol/food interactions
There are 2 alcohol/food interactions with patiromer.
More about patiromer
- patiromer consumer information
- Check interactions
- Compare alternatives
- Reviews (12)
- Side effects
- Dosage information
- During pregnancy
- Drug class: cation exchange resins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.